Relationship between somatostatin receptors and activation of hepatic stellate cells

Chinese Medical Journal

Volumn 117, Issue 11, 2004, Pages 1665-1669

  Pan, Qin ^a   Li, Ding Guo ^a   Lu, Han Ming ^a   Lu, Liang Yong ^b   You, Han Ming ^a   Xu, Qin Fang ^a  

^a XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Research Center for Hepatic Diseases   (China)

Author keywords

Activation; Hepatic stellate cell; Somatostatin receptor

Indexed keywords

CARBON TETRACHLORIDE; MESSENGER RNA; SOMATOSTATIN RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL ISOLATION; CELL MEMBRANE; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; IMMUNOHISTOCHEMISTRY; INTOXICATION; LIVER CELL; LIVER FIBROSIS; LIVER SINUSOID; MALE; NONHUMAN; PERFUSION; PROTEIN EXPRESSION; RAT; RAT STRAIN; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STELLATE CELL;

ANIMALS; LIVER; LIVER CIRRHOSIS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SOMATOSTATIN; RNA, MESSENGER;

EID: 10244266384     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Li H, Zhang J, Huang G, et al. Effect of retinoid kappa receptor alpha (RXRalpha) transfection on the proliferation and phenotype of rat hepatic stellate cells in vitro. Chin Med J 2002;115:928-932.
2. Cireral I, Feu F, Luca A, et al. Effects of bolus injection and continuous infusion of somatostatin and placebo in patients with cirrhosis: a double-blind hemodynamic investigation. Hepatology 1995;22:106-111.
3. Li MK, Sung JJ, Woo KS, et al. Somatostatin reduces gastric mucosa blood flow in patients with portal hypertensive gastropathy, a randomized, double-blind crossover study. Dig Dis Sci 1996;4:2440-2446.
4. Nevens F, Sprengers D, Fevery J. The effect of different doses of a bolus injection of somatostatin combined with a slow infusion on transmural oesophageal variceal pressure in patients with cirrhosis. J Hepatol 1994;20:27-31.
5. Reynaert H, Vaeyens F, Qin H, et al. Somatostatin suppresses endothelin-induced rat hepatic stellate cell contraction via somatostatin receptor subtype 1. Gastroenterology 2001;121:915-930.
6. Gaudillere A, Bernard C, Abello J, et al. Human normal dermal fibroblasts express somatostatin receptors. Exp Dermatol 1999;8:267-273.
7. Pasquali D, Vassallo P, Esposito D, et al. Somatostatin receptor gene expression and inhibitory effects of octreotide on primary cultures of orbital fibroblasts from Graves ophthalmopathy. J Mol Endocrinol 2000;25:63-71.
8. Busto R, Carrero I, Zapata P, et al. Identification of functional somatostatin receptors and G- proteins in new line of human foetal lung fibroblasts. Endocr Res 2000;26:477-486.
9. Ferone D, van Hagen PM, van Koetsveld PM, et al. In vitro characterization of somatostatin in receptors in the human thymus and effects of somatostatin and octreotide on cultured thymic epithelial cells. Endocrinology 1999;140:373-380.
10. Lauder H, Sellers LA, Fan TP, et al. Somatostatin sst5 inhibition of receptor mediated regeneration of rat aortic vascular smooth muscle cells. Br J Pharmacol 1997;122:663-670.
11. Feher E, Fodor M, Feher J. Ultrastructural localization of somatostatin- and substance P-immunoreactive nerve fibers in the feline liver. Gastroenterology 1992;102:287-294.
12. Stoyanova II, Gulubova MV. Immunocytochemical study on the liver innervation in patients with cirrhosis. Acta Hisochem 2000;102:391-402.
13. Tortora G, Yokozaki H, Pepe S, et al. Differentiation of HL-60 leukemia by type I regulatory subunit antisense oligodeoxynucleotide of cAMP-dependent protein kinase. Proc Natl Acad Sci U S A 1991;88:2011-2015.
14. Tahiri JN, Cambillau C, Viguerie N, et al. Characterization of a membrane tyrosine phosphatase in AR42J cells regulation by somatostatin. Am J Physiol 1992;262:G1007-G1014.
15. Ferjoux G, Bousquet C, Cordelier P, et al. Signal transduction of somatostatin receptors negatively controlling cell proliferation. J Physiol Paris 2000;94:205-210.
16. 1 cell cycle arrest. Mol Endocrinol 1999;13:82-90.
17. Lang A, Schoonhoven R, Tuvia S, et al. Nuclear factor kappa B in proliferation, activation, and apoptosis in rat hepatic stellate cells. J Hepatol 2000;33:49-58.
18. Sharma K, Patel YC, Srikant CB. Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3. Mol Endocrinol 1996;10:1688-1696.
19. Sharma K, Srikant CB. Induction of wild-type p53, Bax, and acidic endonuclease during somatostatin-signaled apoptosis in MCF-7 human breast cancer cells. Int J Cancer 1998;76: 259-266.
20. Thangaraju M, Sharma K, Liu D, et al. Interdependent regulation of intracellular acidification and SHP-1 in apoptosis. Cancer Res 1999;59:1649-1654.
21. Zanke BW, Lee C, Arab S, et al. Death of tumor cells after intracellular acidification is dependent on stress-activated protein kinase (SAPK/JNK) pathway activation and cannot be inhibited Bcl-2 expression or interleukin 1 β-converting enzyme inhibition. Cancer Res 1998;58:2801-2808.
22. Liu D, Martino G, Thangaraju M, et al. Caspase-8-mediated intracellular acidification precedes mitochondrial dysfunction in somatostatin-induced apoptosis. J Biol Chem 2000;275: 9244-9250.
23. Thangaraju M, Sharma K, Leber B, et al. Regulation of acidification and apoptosis by SHP-1 and Bel-2. J Biol Chem 1999;274:29549-29557.
24. Teijeiro R, Rios R, Costoya JA, et al. Activation of human somatostatin receptor 2 promotes apoptosis through a mechanism that is independent from induction of p53. Cell Physiol Biochem 2002;12:31-38.
25. 2 gene transfer. Hum Gene Ther 1999;10:995-1008.
26. Peng ZH, Xing TH, Qiu GQ, et al. Relationship between Fas/FasL expression and apoptosis of colon adenocarcinoma cell lines. World J Gastroenterol 2001;7:88-92.